Cadila Healthcare Limited
Report Date | Research house | Description | Reco | At Price | Target Price | UpSide /DownSide | Download |
15-Feb-23
|
KR Choksey
|
Zydus Lifescience reported revenue growth of 19.4% YoY and 5.5% Q..
|
Buy
|
473
|
610
|
29.0
|
|
26-Apr-21
|
Keynotes Finan
|
Cadila Healthcare ltd is the fourth largest pharmaceutical compan..
|
Buy
|
570
|
620
|
8.77
|
|
3-Nov-20
|
Isec
|
Strong growth; significant deleveraging…
|
Buy
|
440
|
555
|
26.1
|
|
3-Jul-20
|
Rudra Shares
|
Strong positioning in diversified product portfolio, ever-increas..
|
BUY
|
366
|
440
|
20.2
|
|
20-Jun-20
|
Motilal Oswal
|
Lower operating/financial leverage outweighs product mix benefit
|
Buy
|
362
|
420
|
16.02
|
|
asdsa
Upcoming Events and Recent Updates
No Recent Updates.